According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type ...
Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...
According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Troponin, CK-MB ...
Sense Diagnostics, Inc. announced that its board of directors has appointed Gary Kurdziel as Chief Executive Officer, ...
The Minister of Indigenous Services, Patty Hajdu, issued the following statement today: "I am pleased to confirm that the Government of Canada has renewed funding for the Inuit Child First Initiative, ...
High brain natriuretic peptide (BNP)/N-terminal prohormone BNP ... Peak VO 2 less than 12-14 ml/kg/min. After more heart failure hospitalization in the past 6 months. Presence of all the above ...
no longer displaying symptoms of heart failure), improvements in KCCQ (median 27-point increase), and substantial improvements in troponin (median reduction 84%) and BNP (median reduction 57% ...
The company already had heart failure data on valsartan ... There are tests, such as a brain natriuretic peptide (BNP) test, which are designed to show how well one's heart is working, but ...
Roger M. Mills, MD, Robert E. Hobbs, MD, James B. Young, MD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback